1. Home
  2. Analysis
  3. Bendamustine-hydrochloride
  4. Urticaria

Bendamustine hydrochloride and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Bendamustine hydrochloride (bendamustine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Adcetris, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Urticaria when taking Bendamustine hydrochloride. It is created by eHealthMe based on reports of 9,160 people who have side effects when taking Bendamustine hydrochloride from the FDA, and is updated regularly.

What is Bendamustine hydrochloride?

Bendamustine hydrochloride has active ingredients of bendamustine hydrochloride. eHealthMe is studying from 9,169 Bendamustine hydrochloride users. Check the latest studies of Bendamustine hydrochloride.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,612 drugs and 2,953 conditions by eHealthMe. Check the latest studies of Urticaria.

On Aug, 11, 2026

9,160 people reported to have side effects when taking Bendamustine hydrochloride.
Among them, 37 people (0.4%) have Urticaria.

Could Bendamustine hydrochloride cause Urticaria?

Among these 37 people:

How long have people been on Bendamustine hydrochloride when they have Urticaria? *

  • < 1 month: 64.29 %
  • 1 - 6 months: 35.71 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urticaria when taking Bendamustine hydrochloride? *

  • female: 23.53 %
  • male: 76.47 %

What is the age of people who have Urticaria when taking Bendamustine hydrochloride? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.11 %
  • 30-39: 3.7 %
  • 40-49: 0.0 %
  • 50-59: 14.81 %
  • 60+: 70.37 %

What are other drugs people take besides Bendamustine hydrochloride? *

  1. Adcetris: 8 people, 21.62%
  2. Bactrim: 5 people, 13.51%
  3. Bleomycin Sulfate: 3 people, 8.11%
  4. Polaramine: 3 people, 8.11%
  5. Dacarbazine: 3 people, 8.11%
  6. Effexor: 2 people, 5.41%
  7. Vitamin D: 1 person, 2.70%
  8. Imbruvica: 1 person, 2.70%
  9. Aranesp: 1 person, 2.70%
  10. Bendamustine: 1 person, 2.70%

What are other side effects people have besides Urticaria? *

  1. Fever: 17 people, 45.95%
  2. Rashes (redness): 12 people, 32.43%
  3. Chills (felling of cold): 11 people, 29.73%
  4. Infection: 9 people, 24.32%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 16.22%
  6. Infusion Related Reaction: 6 people, 16.22%
  7. Fatigue (feeling of tiredness): 6 people, 16.22%
  8. Anaemia (lack of blood): 5 people, 13.51%
  9. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 13.51%
  10. Oral Candidiasis (fungal infection of mouth): 5 people, 13.51%

What are the existing conditions these people have? *

  1. Hodgkin's Lymphoma (cancer originating from white blood cells): 10 people, 27.03%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 16.22%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 10.81%
  4. Angiocentric Lymphoma (extra nodal natural killer cell cancer): 4 people, 10.81%
  5. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 5.41%
  6. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 2.70%
  7. Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 1 person, 2.70%
  8. Non-Hodgkin's Lymphoma Recurrent (reoccurrence malignant (cancer) cells form in the lymph system): 1 person, 2.70%
  9. Mycobacterial Infection: 1 person, 2.70%
  10. Lymphoma (cancer that begins in immune system cells): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Bendamustine hydrochloride and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bendamustine hydrochloride:

Urticaria treatments and more:

How severe was Urticaria and when was it recovered:

Expand to all the drugs that have ingredients of bendamustine hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bendamustine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Browse all the conditions that are associated with Urticaria:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on bendamustine hydrochloride (the active ingredients of Bendamustine hydrochloride) and Bendamustine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.